Deutsch English Français

Contact

EP1251834

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1251834

EP1251834 - REDUCED FORM OF COENZYME Q IN HIGH BIOAVAILABILITY STABLE DOSAGE FORMS AND RELATED APPLICATIONS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 05.04.2015 Database last updated on 03.09.2024
Most recent event Tooltip	13.10.2017	Lapse of the patent in a contracting state New state(s): TR	published on 15.11.2017 [2017/46]
Applicant(s)	For all designated states Chopra, Raj, K. 704 Demott Court Westbury, NY 11590 / US
	[2002/44]
Inventor(s)	01 / see applicant ...
	[2002/44]
Representative(s)	Negrini, Elena Agazzani & Associati S.r.l. Studio Ing. Giampaolo Agazzani Via dell'Angelo Custode 11/6 40141 Bologna / IT
	[2014/22]
Former [2002/44]	Negrini, Elena Agazzani & Associati S.r.l. & Studio Ing. Giampaolo Agazzani, Via dell'Angelo Custode 11/6 40141 Bologna / IT
Application number, filing date	01942547.9	18.01.2001
	[2002/44]
	WO2001US01997
Priority number, date	US20000488332	20.01.2000 Original published format: US 488332
	US20000637559	11.08.2000 Original published format: US 637559
	[2002/44]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0152822
	Date:	26.07.2001
	Language:	EN
	[2001/30]
	Type:	A1 Application with search report
	No.:	EP1251834
	Date:	30.10.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.07.2001 takes the place of the publication of the European patent application.
	[2002/44]
	Type:	B1 Patent specification
	No.:	EP1251834
	Date:	28.05.2014
	Language:	EN
	[2014/22]
Search report(s)	International search report - published on:	US	26.07.2001
	(Supplementary) European search report - dispatched on:	EP	08.10.2008
Classification	IPC:	A61K9/48, A61K9/66, A61K9/64, A61K9/20	[2002/44]
	CPC:	A61K9/4858 (EP,US); A61K9/0031 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/44]
Title	German:	REDUZIERTE FORM DES COENZYMS Q IN STABILEN DARREICHUNGSFORMEN MIT HOHER BIOFERFÜGBARKEIT UND DAMIT VERBUNDENE ANWENDUNGEN	[2002/44]
	English:	REDUCED FORM OF COENZYME Q IN HIGH BIOAVAILABILITY STABLE DOSAGE FORMS AND RELATED APPLICATIONS	[2002/44]
	French:	FORME REDUITE DE COENZYME Q DANS DES FORMES POSOLOGIQUES STABLES A HAUTE BIODISPONIBILITE ET APPLICATIONS CORRESPONDANTES	[2002/44]
Entry into regional phase	20.08.2002	National basic fee paid
	20.08.2002	Search fee paid
	20.08.2002	Designation fee(s) paid
	20.08.2002	Examination fee paid
Examination procedure	03.07.2001	Request for preliminary examination filed International Preliminary Examining Authority: US
	19.08.2002	Amendment by applicant (claims and/or description)
	20.08.2002	Examination requested [2002/44]
	01.07.2009	Despatch of a communication from the examining division (Time limit: M06)
	29.12.2009	Reply to a communication from the examining division
	17.06.2011	Despatch of a communication from the examining division (Time limit: M06)
	19.12.2011	Reply to a communication from the examining division
	25.09.2013	Cancellation of oral proceeding that was planned for 29.10.2013
	29.10.2013	Date of oral proceedings (cancelled)
	21.11.2013	Communication of intention to grant the patent
	20.03.2014	Fee for grant paid
	20.03.2014	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.07.2009
Opposition(s)	03.03.2015	No opposition filed within time limit [2015/19]
Fees paid	Renewal fee
	31.01.2003	Renewal fee patent year 03
	02.02.2004	Renewal fee patent year 04
	31.01.2005	Renewal fee patent year 05
	31.01.2006	Renewal fee patent year 06
	31.01.2007	Renewal fee patent year 07
	31.01.2008	Renewal fee patent year 08
	02.02.2009	Renewal fee patent year 09
	01.02.2010	Renewal fee patent year 10
	31.01.2011	Renewal fee patent year 11
	31.01.2012	Renewal fee patent year 12
	31.01.2013	Renewal fee patent year 13
	31.01.2014	Renewal fee patent year 14
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	IT	28.05.2014
	MC	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	TR	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
	IE	18.01.2015
	LU	18.01.2015
	[2017/46]
Former [2016/07]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	IT	28.05.2014
	MC	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
	IE	18.01.2015
	LU	18.01.2015
Former [2015/43]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	IT	28.05.2014
	MC	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
	LU	18.01.2015
Former [2015/39]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	IT	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
	LU	18.01.2015
Former [2015/22]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	IT	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
Former [2015/12]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	NL	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
Former [2015/10]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	ES	28.05.2014
	FI	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
Former [2015/08]	AT	28.05.2014
	BE	28.05.2014
	CY	28.05.2014
	DK	28.05.2014
	FI	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
Former [2015/02]	AT	28.05.2014
	CY	28.05.2014
	FI	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
	PT	29.09.2014
Former [2014/51]	AT	28.05.2014
	CY	28.05.2014
	FI	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
Former [2014/50]	CY	28.05.2014
	FI	28.05.2014
	SE	28.05.2014
	GR	29.08.2014
Former [2014/49]	CY	28.05.2014
	FI	28.05.2014
Former [2014/47]	CY	28.05.2014
Documents cited:	Search	[A]DE3405581 (SIGMA TAU IND FARMACEUTI [IT]) [A] 1-34 * claim - *;
		[A]EP0383432 (MERCK & CO INC [US]) [A] 1-34* claim - *;
		[A]WO9803170 (BIOSYTES USA INC [US]) [A] 1-34 * claim - *;
		[X]EP0882450 (KANEKA CORP [JP]) [X] 1,8,20-22,25,30 * example 4 *;
		[X]EP0956854 (KANEKA CORP [JP]) [X] 1,8,20-22,25,27 * example 4 *
	International search	[A]US4869900 (POZZI FRANCO [IT], et al);
		[AP]US6045826 (BOROWY-BOROWSKI HENRYK [CA], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p